Psychedelics

Marvel Biosciences starts work on psychedelics-inspired compounds

The Calgary-based life sciences company hopes to develop treatments for mental health conditions.

0

Love Pharma to develop psilocybin-infused oral strips

Sublingual or the administration of medicines under the tongue allows for quick absorption.

0

Cybin Inc. seeks patent for inhalation delivery of psychedelic medications

The Toronto company is developing a psychedelic drug for anxiety disorders.

0

Academic reflects on bioethical issues in medicalization of psychedelics

Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.

0

Nova Mentis looks at potential psilocybin treatment for obesity and diabetes

People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.

0

Awakn Life Sciences starts study on ketamine treatment for gambling addiction

Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.

0